Adragos Pharma
Germany
Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Adragos Pharma is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Neurology
Quick Facts
HQ:Germany
Founded:1995
Employees:3,050
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Technology Platforms
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
North America
Europe
Manufacturing Facilities
5 sites worldwide
Adragos Pharma - Germany Facility
Germany
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Adragos Pharma - Greece Facility
Greece
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Adragos Pharma - Italy Facility
Italy
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Adragos Pharma - Japan Facility
Japan
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Adragos Pharma - Spain Facility
Spain
Site Capabilities
Gene Therapy
Cell Therapy
mRNA
Customer Reviews
4.1
Overall Rating
Project Management3.5
Technology Transfer4.3
On-Time Delivery4.2
Communication Responsiveness3.8
Innovation4.9
Company Documents
No documents available.
Loading CDMO intelligence...